Optimum scanning protocol for FDG-PET evaluation of pulmonary malignancy

Val Lowe, D. M. DeLong, J. M. Hoffman, R. E. Coleman

Research output: Contribution to journalArticle

100 Citations (Scopus)

Abstract

FDG-PET can differentiate benign from malignant focal pulmonary opacities. We performed dynamic FDG-PET studies to determine the optimum time for emission data acquisition. Methods: Patients with focal pulmonary abnormalities demonstrated by biopsy to be malignant (n = 10) or benign (n = 4) were evaluated with dynamic FDG-PET. Dynamic PET data were acquired as sequential 5-min images for 2.5 hr. Radioactivity concentration measurements of the focal abnormality, a similar ares in the opposite lung, and both lungs in the field of view were made throughout the period of acquisition. Standardized uptake ratios (SUR) of the lesions were calculated. SUR data and lesion-to-background ratios were plotted. The time that the SUR provided the maximum separation between benign and malignant masses after FDG administration was determined. Results: The SUR values provided the greatest separation between benign and malignant abnormalities beginning at 50 min and no advantage was identified in imaging later. Achievement of a 4:1 lesion- to-background ratio occurred by 50 min in malignant lesions. Conclusion: The acquisition of the emission data used in the evaluation of pulmonary malignancy should begin approximately 50 min after FDG administration.

Original languageEnglish (US)
Pages (from-to)883-887
Number of pages5
JournalJournal of Nuclear Medicine
Volume36
Issue number5
StatePublished - 1995
Externally publishedYes

Fingerprint

Lung
Neoplasms
Radioactivity
PET protocol
Biopsy

Keywords

  • fluorine-18-fluorodeoxyglucose
  • lung neoplasms
  • positron emission tomography

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

Lowe, V., DeLong, D. M., Hoffman, J. M., & Coleman, R. E. (1995). Optimum scanning protocol for FDG-PET evaluation of pulmonary malignancy. Journal of Nuclear Medicine, 36(5), 883-887.

Optimum scanning protocol for FDG-PET evaluation of pulmonary malignancy. / Lowe, Val; DeLong, D. M.; Hoffman, J. M.; Coleman, R. E.

In: Journal of Nuclear Medicine, Vol. 36, No. 5, 1995, p. 883-887.

Research output: Contribution to journalArticle

Lowe, V, DeLong, DM, Hoffman, JM & Coleman, RE 1995, 'Optimum scanning protocol for FDG-PET evaluation of pulmonary malignancy', Journal of Nuclear Medicine, vol. 36, no. 5, pp. 883-887.
Lowe, Val ; DeLong, D. M. ; Hoffman, J. M. ; Coleman, R. E. / Optimum scanning protocol for FDG-PET evaluation of pulmonary malignancy. In: Journal of Nuclear Medicine. 1995 ; Vol. 36, No. 5. pp. 883-887.
@article{1eb66753afd04702bacd2536ebe412e7,
title = "Optimum scanning protocol for FDG-PET evaluation of pulmonary malignancy",
abstract = "FDG-PET can differentiate benign from malignant focal pulmonary opacities. We performed dynamic FDG-PET studies to determine the optimum time for emission data acquisition. Methods: Patients with focal pulmonary abnormalities demonstrated by biopsy to be malignant (n = 10) or benign (n = 4) were evaluated with dynamic FDG-PET. Dynamic PET data were acquired as sequential 5-min images for 2.5 hr. Radioactivity concentration measurements of the focal abnormality, a similar ares in the opposite lung, and both lungs in the field of view were made throughout the period of acquisition. Standardized uptake ratios (SUR) of the lesions were calculated. SUR data and lesion-to-background ratios were plotted. The time that the SUR provided the maximum separation between benign and malignant masses after FDG administration was determined. Results: The SUR values provided the greatest separation between benign and malignant abnormalities beginning at 50 min and no advantage was identified in imaging later. Achievement of a 4:1 lesion- to-background ratio occurred by 50 min in malignant lesions. Conclusion: The acquisition of the emission data used in the evaluation of pulmonary malignancy should begin approximately 50 min after FDG administration.",
keywords = "fluorine-18-fluorodeoxyglucose, lung neoplasms, positron emission tomography",
author = "Val Lowe and DeLong, {D. M.} and Hoffman, {J. M.} and Coleman, {R. E.}",
year = "1995",
language = "English (US)",
volume = "36",
pages = "883--887",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "5",

}

TY - JOUR

T1 - Optimum scanning protocol for FDG-PET evaluation of pulmonary malignancy

AU - Lowe, Val

AU - DeLong, D. M.

AU - Hoffman, J. M.

AU - Coleman, R. E.

PY - 1995

Y1 - 1995

N2 - FDG-PET can differentiate benign from malignant focal pulmonary opacities. We performed dynamic FDG-PET studies to determine the optimum time for emission data acquisition. Methods: Patients with focal pulmonary abnormalities demonstrated by biopsy to be malignant (n = 10) or benign (n = 4) were evaluated with dynamic FDG-PET. Dynamic PET data were acquired as sequential 5-min images for 2.5 hr. Radioactivity concentration measurements of the focal abnormality, a similar ares in the opposite lung, and both lungs in the field of view were made throughout the period of acquisition. Standardized uptake ratios (SUR) of the lesions were calculated. SUR data and lesion-to-background ratios were plotted. The time that the SUR provided the maximum separation between benign and malignant masses after FDG administration was determined. Results: The SUR values provided the greatest separation between benign and malignant abnormalities beginning at 50 min and no advantage was identified in imaging later. Achievement of a 4:1 lesion- to-background ratio occurred by 50 min in malignant lesions. Conclusion: The acquisition of the emission data used in the evaluation of pulmonary malignancy should begin approximately 50 min after FDG administration.

AB - FDG-PET can differentiate benign from malignant focal pulmonary opacities. We performed dynamic FDG-PET studies to determine the optimum time for emission data acquisition. Methods: Patients with focal pulmonary abnormalities demonstrated by biopsy to be malignant (n = 10) or benign (n = 4) were evaluated with dynamic FDG-PET. Dynamic PET data were acquired as sequential 5-min images for 2.5 hr. Radioactivity concentration measurements of the focal abnormality, a similar ares in the opposite lung, and both lungs in the field of view were made throughout the period of acquisition. Standardized uptake ratios (SUR) of the lesions were calculated. SUR data and lesion-to-background ratios were plotted. The time that the SUR provided the maximum separation between benign and malignant masses after FDG administration was determined. Results: The SUR values provided the greatest separation between benign and malignant abnormalities beginning at 50 min and no advantage was identified in imaging later. Achievement of a 4:1 lesion- to-background ratio occurred by 50 min in malignant lesions. Conclusion: The acquisition of the emission data used in the evaluation of pulmonary malignancy should begin approximately 50 min after FDG administration.

KW - fluorine-18-fluorodeoxyglucose

KW - lung neoplasms

KW - positron emission tomography

UR - http://www.scopus.com/inward/record.url?scp=0029040275&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029040275&partnerID=8YFLogxK

M3 - Article

C2 - 7738668

AN - SCOPUS:0029040275

VL - 36

SP - 883

EP - 887

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 5

ER -